Managers / Q1 2026
Weaver C. Barksdale & Associates, Inc.
CIK 0001294588 · 40 BURTON HILLS BLVD., SUITE 230, NASHVILLE, TN, 37215 · 615-665-1085
Summary
Weaver C. Barksdale & Associates, Inc. reported $105M in U.S.-listed holdings across 62 positions for Q1 2026.
Its largest position, CMI, represents 2.3% of the portfolio.
Compared with Q4 2025, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.2% · $98M
- Other · 3.6% · $4M
- REIT · 3.2% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ACCENTURE PLC IRELAND | NEW | +9.6K | 9.6K | +$2M | $2M |
| ADPAUTOMATIC DATA PROCESSING IN | NEW | +9.3K | 9.3K | +$2M | $2M |
| AREALEXANDRIA REAL ESTATE EQ | SOLD OUT | −21.5K | 0 | −$1M | $0 |
| TFCTRUIST FINL CORP | SOLD OUT | −18.8K | 0 | −$926,566 | $0 |
| CAHCARDINAL HEALTH INC | ADDED | +897 | 4.9K | +$212,663 | $1M |
| MEDTRONIC PLC | ADDED | +1.3K | 7.2K | +$58,696 | $621,800 |
| LMTLOCKHEED MARTIN CORP | TRIMMED | −494 | 3.4K | +$163,944 | $2M |
| HSYHERSHEY CO | ADDED | +531 | 7.8K | +$297,155 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $105M | 62 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $95M | 62 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 62 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 62 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $104M | 62 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $104M | 62 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $111M | 62 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $105M | 62 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $109M | 62 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $102M | 62 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $117M | 62 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $101M | 62 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $107M | 62 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $113M | 62 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $100M | 63 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $107M | 63 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $112M | 61 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $110M | 59 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.